This exclusive subscriber-only event…
- Provides a comprehensive overview of our remaining recommendations right now. (Top THREE recommendations were covered in Part 1). The review includes the significance of the latest company developments, Q3 reports, upcoming catalysts, risks, competitive threats, as well as price and profit targets.
- Highlights additional market perspective and dynamics as we start 2022, including the key considerations to keep in mind regarding the biotech sector and small/micro cap stocks.
- Addresses members questions, regarding companies, DTR strategy and tech trends.
Please click on the play button below to listen.
This content is reserved for subscribers. But for a limited time only you can use Coupon Code DTR2022 to subscribe at the lowest price we’ve ever offered for an annual subscription.